Bone demineralization happens when minerals, primarily calcium and phosphate, are lost from the bone matrix faster than the body can replace them. The result is weaker, more porous bones that fracture more easily. The process can stem from dozens of causes, from vitamin D deficiency and hormonal changes to chronic kidney disease, and it often progresses silently for years before a fracture or a routine scan reveals the damage. Understanding what drives mineral loss, what the warning signs look like, and what actually reverses it can make the difference between catching the problem early and dealing with a broken hip.
How Bones Gain and Lose Their Minerals
Bone is not a static structure. Throughout your life, specialized cells are constantly tearing down old bone and building new bone in its place. The cells that break bone down are called osteoclasts; the cells that build it back up are osteoblasts. When these two teams are in balance, your skeleton stays strong. Demineralization occurs when osteoclast activity outpaces osteoblast activity, or when the raw materials needed to mineralize new bone tissue simply are not available.
A major signaling system that controls this balance involves a molecule called RANKL, which tells osteoclast precursors to mature into active bone-dissolving cells. A counterpart molecule, OPG, acts as a decoy by binding RANKL before it can do its job, thereby protecting bone from excessive breakdown. The relative levels of these two molecules in bone tissue are one of the biggest determinants of whether you are gaining or losing mineral.1PubMed Central. Functions of RANKL/RANK/OPG in bone modeling and remodeling Research has shown that cells sitting along the bone surface are the most abundant source of RANKL, while cells embedded deeper in bone and bone-forming osteoblasts tend to produce more OPG.2Bone Research. Mapping RANKL- and OPG-expressing cells in bone tissue Any disease, drug, or deficiency that tips this ratio toward more RANKL and less OPG pushes you toward demineralization.
In a separate but related problem, bone can form new tissue that simply fails to mineralize properly. This is what happens in osteomalacia, a condition marked by excessive accumulation of soft, unmineralized bone matrix. The distinction matters: osteoporosis is about losing too much bone altogether, while osteomalacia is about building bone that never hardens. In practice, many people with severe vitamin D deficiency wind up with elements of both.
The Major Causes
Demineralization rarely comes from a single factor. More often, several risks stack on top of one another. But some causes stand well above others in terms of how common they are and how severe their effects can be.
Vitamin D Deficiency
Vitamin D is central to calcium absorption. Without enough of it, your intestines simply cannot pull adequate calcium from the food you eat, and your kidneys struggle to hold on to the calcium already in your blood. The active form of vitamin D works by switching on genes that control calcium transport in the gut and phosphate handling in the kidneys.3Calcified Tissue International. Molecular mechanisms of vitamin D action When vitamin D levels drop too low, the body compensates by pulling calcium from the skeleton. Prolonged deficiency leads to the soft, poorly mineralized bone seen in osteomalacia, along with muscle weakness, fatigue, and a distinctive waddling gait caused by weakness in the hips and thighs.4PubMed Central. Concealing Clothing Leading to Severe Vitamin D Deficiency, Osteomalacia and Muscle Weakness People at highest risk include those who get very little sun exposure, individuals with darker skin at northern latitudes, and older adults whose skin synthesizes vitamin D less efficiently.
Estrogen Loss After Menopause
Estrogen is one of the skeleton’s most important protectors. It promotes the production of OPG (the molecule that blocks bone breakdown) and suppresses RANKL (the molecule that drives it).5PubMed Central. Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover When estrogen drops at menopause, the brake on osteoclast activity loosens. Research has shown that estrogen directly triggers osteoclast death, so losing it means these bone-dissolving cells live longer and do more damage.6Cell Metabolism. Estrogen and Bone: Osteoclasts Take Center Stage This is why postmenopausal women account for a disproportionate share of osteoporotic fractures. The bone loss is fastest in the first five to seven years after menopause, making that window a critical time for screening and intervention.
Corticosteroid Use
Glucocorticoids such as prednisone are among the most widely prescribed anti-inflammatory drugs, and they are also one of the most common drug-related causes of bone loss. Even at low doses, prednisone rapidly reduces markers of bone formation.7PubMed. Effects of low-dose prednisone on bone metabolism The damage is two-sided: corticosteroids suppress osteoblast function while simultaneously ramping up osteoclast activity, disrupting the remodeling balance from both directions.8PubMed Central. Beneath the Surface: Exploring Hidden Threats of Long-Term Corticosteroid Therapy to Bone Density If you take oral steroids for conditions like asthma, rheumatoid arthritis, or inflammatory bowel disease, your doctor should be monitoring your bone health. The good news from the low-dose prednisone data is that much of the suppression reverses once the drug is stopped, but prolonged use can cause damage that is harder to undo.
Gut Disorders and Nutrient Malabsorption
Your bones can only be as strong as the nutrition your gut can deliver. Celiac disease is a prime example: the autoimmune reaction damages the intestinal lining, impairing absorption of calcium and other minerals. Calcium malabsorption and skeletal demineralization are well-recognized features of untreated celiac disease.9PubMed. Calcium absorption and bone mineral density in celiacs after long term treatment with gluten-free diet and adequate calcium intake On top of the absorption issue, the inflammatory process itself triggers osteoclast activation, compounding the mineral loss.10PubMed Central. Osteoporosis Can Be the Sole Presentation in Celiac Disease Osteoporosis can sometimes be the only visible sign that someone has celiac disease, which means a DEXA scan showing unexplained bone loss in a younger person should prompt consideration of gut-related causes.
Chronic Kidney Disease
The kidneys play a direct role in activating vitamin D and regulating phosphate. When they start to fail, a cascade of metabolic changes hits the skeleton. Renal osteodystrophy, the bone disorder linked to chronic kidney disease, affects virtually all adults and children with significant kidney impairment. Fracture rates in adults with chronic kidney disease are two-fold to 100-fold higher than in people with healthy kidneys, depending on the stage of disease and type of fracture.11PubMed Central. Renal osteodystrophy: something old, something new, something needed Managing bone health in kidney disease is especially tricky because some standard osteoporosis drugs are cleared by the kidneys and can accumulate to harmful levels.
Proton Pump Inhibitors
A cause that catches many people off guard is long-term use of acid-suppressing medications like omeprazole and lansoprazole. These drugs, known as proton pump inhibitors, are taken by millions of people for heartburn and acid reflux. Observational evidence has linked their extended use to increased risk of fractures at the hip, spine, and wrist.12PubMed Central. Proton Pump Inhibitors and Bone Health: An Update Narrative Review The suspected mechanism involves reduced stomach acid impairing calcium absorption, though the exact pathway remains debated. If you have been on a PPI for years, it is worth discussing with your doctor whether the dose can be lowered or whether an alternative makes sense.
Symptoms That Tend to Sneak Up
The frustrating reality of bone demineralization is that it rarely announces itself. Osteoporosis is often called a “silent” condition because you can lose substantial bone density without feeling any different. The first symptom for many people is a fracture from a fall that would not have broken a healthy bone, or sometimes a fracture with no memorable fall at all.
When osteomalacia is the problem, symptoms tend to be more noticeable but are frequently blamed on other things. Dull, aching bone pain, especially in the lower back, pelvis, and legs, is common. Muscle weakness concentrated in the hips and shoulders can make climbing stairs or getting out of a chair difficult. In a documented case of severe vitamin D deficiency, a 51-year-old woman presented with progressive weakness of the arms and legs, extreme fatigue, chest and spine pain, tingling sensations, and depression before the underlying bone condition was identified.4PubMed Central. Concealing Clothing Leading to Severe Vitamin D Deficiency, Osteomalacia and Muscle Weakness These symptoms overlap with so many other conditions that osteomalacia can go misdiagnosed for months or years.
Height loss is another underappreciated clue. Compression fractures of the vertebrae can occur silently, and over time they cause a measurable loss of stature and a forward curvature of the upper back. Losing more than about an inch and a half of height from your peak is a signal that warrants investigation.
How Demineralization Is Diagnosed
The standard screening tool is a DEXA scan, which uses low-dose X-rays to measure bone mineral density at the hip and spine. The result is expressed as a T-score, which compares your density to that of a healthy young adult. A T-score of –1.0 or higher is considered normal, between –1.0 and –2.5 indicates reduced density (osteopenia), and –2.5 or lower qualifies as osteoporosis.13PubMed Central. DEXA and Imaging in Osteoporosis DEXA is quick, painless, and widely available, but it has limitations. It measures density across a flat area, so it can miss changes in bone quality or be thrown off by things like arthritis or aortic calcification overlying the spine.
Blood tests add useful context. Vitamin D and calcium levels help identify deficiency-driven demineralization. Parathyroid hormone (PTH) is checked because persistently high PTH signals the body is actively pulling calcium from bone. Blood markers of bone turnover can also be informative. Markers that reflect bone breakdown tend to rise as density falls: in one study of postmenopausal women, bone resorption markers showed inverse correlations with density at both the spine and the hip.14Frontiers in Endocrinology. Bone turnover markers (β-CTX, PINP, ALP) in osteoporosis: correlation with bone loss and fracture risk stratification These markers are not used alone to diagnose osteoporosis, but they help track whether a treatment is working faster than waiting years for a follow-up DEXA.
Medication Options for Rebuilding Bone
Drug therapy for demineralized bone falls into two broad categories: treatments that slow bone breakdown and treatments that stimulate new bone formation. In recent years, a third strategy has emerged that does both simultaneously.
Drugs That Slow Breakdown
Bisphosphonates, including alendronate (Fosamax) and risedronate (Actonel), have been the most widely prescribed osteoporosis drugs for decades. They work by binding directly to the mineral surface of bone and interfering with osteoclast function, effectively poisoning the cells that dissolve bone.15PubMed. Denosumab and bisphosphonates: different mechanisms of action and effects They are effective, but because they embed in bone, their effects linger for years after you stop taking them, which is both an advantage and a source of rare side effects with very long-term use.
Denosumab (Prolia) represents a more targeted approach. It is a lab-made antibody that binds directly to RANKL, the signaling molecule that tells osteoclasts to form and survive. By neutralizing RANKL, denosumab causes a potent reduction in bone breakdown.16Nature Reviews Rheumatology. Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on bone It is given as an injection every six months. One important caveat: unlike bisphosphonates, denosumab’s effects are fully reversible. If you stop taking it without transitioning to another therapy, bone loss can rebound rapidly, sometimes leading to multiple vertebral fractures in a short period. Careful planning around discontinuation is essential.
Drugs That Build New Bone
For people who have already suffered fractures or have very low density, bone-building drugs offer something anti-resorptives cannot: actual gains in bone mass. Teriparatide (Forteo) is a synthetic fragment of parathyroid hormone. Given as a daily injection, it stimulates osteoblasts to lay down new bone. It sounds counterintuitive, since excess parathyroid hormone normally drives bone loss. The key is the delivery: a brief daily pulse of the hormone preferentially activates bone-building pathways rather than bone-dismantling ones.
Romosozumab (Evenity) is the newest entrant and arguably the most exciting. It blocks a protein called sclerostin that normally puts the brakes on bone formation, so inhibiting it both increases building and decreases breakdown at the same time. In a meta-analysis comparing romosozumab with teriparatide in postmenopausal women, romosozumab produced significantly greater gains in bone density over 12 months.17PubMed Central. Romosozumab versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: A Systematic Review and Meta‐analysis through a Grade Analysis of Evidence In a separate trial, romosozumab increased vertebral strength by about 27% compared with roughly 19% for teriparatide over the same period, and also outperformed teriparatide on hip cortical thickness and density.18Journal of Bone and Mineral Research. Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass 19JBMR Plus. Effects of romosozumab and teriparatide on hip bone using 3D-SHAPER in postmenopausal women with osteoporosis Romosozumab is given for just 12 months and is then typically followed by an anti-resorptive drug to maintain the gains. It does carry a warning about cardiovascular risk, so it is not suitable for everyone.
Exercise and Nutrition as Bone Medicine
Medication gets the headlines, but exercise is one of the few interventions that both builds bone and reduces falls, addressing fracture risk from two angles. The type of exercise matters more than most people realize. Walking alone, while valuable for general health, does not appear to actively increase bone density. It can, however, slow the rate of loss, which still counts for something.20PubMed Central. The Effectiveness of Physical Exercise on Bone Density in Osteoporotic Patients For actual gains in density, the bones need stronger mechanical signals. Resistance training, including lifting weights and using resistance bands, applies larger forces to the skeleton and stimulates osteoblasts to form new bone tissue.21Scientific Reports. Effect of different types of exercise on bone mineral density in postmenopausal women: a systematic review and network meta-analysis Impact activities like jogging, stair climbing, and jumping exercises are also effective, as long as the force going through the bones is meaningfully above what you produce during normal daily movement.
On the nutrition side, calcium and vitamin D supplementation are standard recommendations, but the evidence on how much they help is more nuanced than supplement marketing would suggest. Calcium taken together with vitamin D does appear to increase bone density modestly, but vitamin D taken alone does not seem to move the needle on density or fracture rates in most studies. What vitamin D supplementation reliably does is raise blood levels of the vitamin and reduce parathyroid hormone, which is valuable if you are deficient but less meaningful if your levels are already adequate.22PubMed Central. Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTs Getting enough calcium from food first and supplementing only when dietary intake falls short is a sensible approach, partly because very high-dose calcium supplements have raised some concerns about cardiovascular risk in certain populations.
Bone Loss in Space
One of the more striking demonstrations of how sensitive bones are to their mechanical environment comes from space travel. Astronauts in microgravity lose bone at a dramatically accelerated rate compared to normal age-related loss on Earth. The cause is straightforward: without gravity pulling on the skeleton, the mechanical stimulus that keeps bone-building cells active essentially disappears. Studies of space travelers have found that while both bone formation and bone resorption increase in microgravity, the increase in resorption is larger, resulting in net mineral loss.23PubMed Central. Microgravity-Related Changes in Bone Density and Treatment Options: A Systematic Review This is a real barrier to long-duration missions to Mars and beyond. Current countermeasures on the International Space Station include hours of daily resistance exercise, and researchers are testing whether bisphosphonates or other drugs might provide additional protection during extended flights. For people on Earth, the space data underscores why prolonged bed rest or immobility is so damaging to the skeleton, and why getting back on your feet after an injury or surgery is pushed so aggressively by physical therapists.